A high eosinophil level, for example, can indicate a range of several health conditions, from allergic reactions and asthma ...

In people with HES, chronically elevated eosinophil levels can infiltrate the body’s tissues, causing inflammation and organ ...

What Is the Next Step in the Protocol for the Diagnosis of ABPA? A peripheral blood eosinophil count, serum precipitins (or IgG) against A. fumigatus and a chest radiograph along with a high ...

EMA approves Dupixent to treat eosinophilic esophagitis in children as young as one year: Paris Thursday, November 7, 2024, 14:00 Hrs [IST] The European Medicines Agency has appro ...

As AstraZeneca builds up indications for Fasenra, an ongoing trial will determine whether the respiratory drug can make up ...

Patients with asthma who switched biologics multiple times were younger, more likely to identify as Black, and had more ...

METREX involved patients with a range of eosinophil levels and showed a statistically significant improvement for Nucala versus placebo on exacerbation rates. However, in METREO – which focused ...

For the current phase 3 trial, participants were required to have a peak eosinophil count (PEC) of ≥ 15 eosinophils (eos)/high power field (hpf) and 4 or more days of dysphagia over the 2 weeks ...

This investigational trial will evaluate the effects of three dose levels of oral dexpramipexole for 12 weeks on peripheral blood eosinophil count, lung function, and asthma control. Additionally ...

Paris: Sanofi has announced that the European Medicines Agency has approved Dupixent (dupilumab) to treat eosinophilic ...

Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitisApproval based on phase 3 data showing ...

Approval based on Phase 3 data showing significantly more children aged 1 to 11 years on Dupixent achieved histological disease remission at 16 ...